Industry wide, clinical trial protocols continue to increase in complexity over time. This webinar adds to the growing evidence of which elements of trial design and strategy correlate with lower study recruitment, increased timelines, and cost.
Connecting protocol complexity with trial outcomes provides the insights to allow for better designed protocols that sites and patients want to participate in, with less potential for operational errors resulting in deviations and amendments and determining efficacy and safety more efficiently — moving potential treatments more swiftly to patients who need them.
Denise Messer
Design Analytics Director
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
